Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Fu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Society of Nephrology : JASN|October 16, 2010
Rate of kidney function decline associates with mortalityZiyad Al-Aly, Angelique Zeringue, John Fu, et al.
Human & Experimental Toxicology|October 13, 2010
Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathwaysHsu-Feng Lu, Yu-Jie Chie, Ming-Sung Yang, et al.
International Journal of Oncology|April 30, 2010
Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathwayHsu-Feng Lu, Yu-Jie Chie, Ming-Sung Yang, et al.
Journal for Immunotherapy of Cancer|July 2, 2020
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort studyXue Bai, De-Hua Wu, Si-Cong Ma, et al.
Oncoimmunology|May 17, 2021
Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studiesSi-Cong Ma, Xin-Ran Tang, Li-Li Long, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
BMC Medicine|April 12, 2022
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practiceSi-Cong Ma, Xue Bai, Xue-Jun Guo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Society of Nephrology : JASN|October 16, 2010
Rate of kidney function decline associates with mortalityZiyad Al-Aly, Angelique Zeringue, John Fu, et al.
Human & Experimental Toxicology|October 13, 2010
Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathwaysHsu-Feng Lu, Yu-Jie Chie, Ming-Sung Yang, et al.
International Journal of Oncology|April 30, 2010
Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathwayHsu-Feng Lu, Yu-Jie Chie, Ming-Sung Yang, et al.
Journal for Immunotherapy of Cancer|July 2, 2020
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort studyXue Bai, De-Hua Wu, Si-Cong Ma, et al.
Oncoimmunology|May 17, 2021
Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studiesSi-Cong Ma, Xin-Ran Tang, Li-Li Long, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
BMC Medicine|April 12, 2022
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practiceSi-Cong Ma, Xue Bai, Xue-Jun Guo, et al.
Pageof 2